Le Lézard
Classified in: Health
Subject: LBR

CALIFORNIA PUBLIC HEALTH OFFICIALS JOIN TEAMSTERS


Workers Vote Unanimously to Join Teamsters Local 665

COTATI, Calif., April 29, 2024 /PRNewswire/ -- Workers at the Marin/Sonoma Mosquito and Vector Control District have voted unanimously to join Teamsters Local 665. The 33 new members protect the health and welfare of residents in Marin and Sonoma counties from mosquitoes and vector-borne diseases.

"Congratulations to the newest members of the Teamsters Local 665 family," said Mike Yates, President of Local 665 in San Francisco. "Residents across Marin and Sonoma counties benefit from the important work done by these public health officials to keep our communities safe. We are looking forward to helping them bargain their first Teamsters contract and address workers' key priorities."

The workers specifically handle mosquito control, delivery of mosquitofish, ground nesting yellowjacket control, and rodent prevention and control advice.

"We are delighted to announce our affiliation with Teamsters Local 665. We eagerly anticipate collaborating with them and entrusting them with our representation," said Nizza Sequeira, a public information officer. "Together, we look forward to championing the interests of our dedicated team."

Teamsters Local 665 represents 5,000 working members in nine counties in many diverse industries in Northern California and the San Francisco Bay Area. For more information, visit Teamsters665.org.

Contact:
Daniel Moskowitz, (770) 262-4971
[email protected]

SOURCE Teamsters Local 665


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: